About Precision Biologics
Precision Biologics is a company based in Dallas (United States) founded in 2012 was acquired by NantWorks in October 2015. It operates as a HealthTech. Precision Biologics has raised $14.58 million across 3 funding rounds from investors including NantWorks. The company has 4 employees as of December 31, 2022. Precision Biologics has completed 1 acquisition, including Neogenix Oncology. Precision Biologics offers products and services including Anticancer Vaccines, Monoclonal Antibodies, and Antibody-Drug Conjugate PB-223 ADC. Precision Biologics operates in a competitive market with competitors including Jazz Pharmaceuticals, Moderna, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Dallas, United States
- Employees 4 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Precision Biologics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.58 M (USD)
in 3 rounds
-
Latest Funding Round
$795 K (USD), Series A
Apr 02, 2014
- Investors
-
Employee Count
4
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
NantWorks
(Oct 19, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Precision Biologics
Precision Biologics offers a comprehensive portfolio of products and services, including Anticancer Vaccines, Monoclonal Antibodies, and Antibody-Drug Conjugate PB-223 ADC. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Patient tumor-derived vaccines are developed for cancer treatment.
Targeted antibodies are designed for tumor-specific cancer therapy.
Innovative conjugate is created for targeted cancer drug delivery.
Unlock access to complete
Unlock access to complete
Funding Insights of Precision Biologics
Precision Biologics has successfully raised a total of $14.58M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $795 thousand completed in April 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $795,000
-
First Round
First Round
(21 May 2013)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2014 | Amount | Series A - Precision Biologics | Valuation |
investors |
|
| Dec, 2013 | Amount | Series A - Precision Biologics | Valuation |
investors |
|
| May, 2013 | Amount | Series A - Precision Biologics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Precision Biologics
Precision Biologics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include NantWorks. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Network of technology and infrastructure companies focused on healthcare development
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Precision Biologics
Precision Biologics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Neogenix Oncology. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutic and diagnostic antibodies are developed for cancer treatments.
|
2003 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Precision Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Precision Biologics Comparisons
Competitors of Precision Biologics
Precision Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Moderna, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Precision Biologics
Frequently Asked Questions about Precision Biologics
When was Precision Biologics founded?
Precision Biologics was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Precision Biologics located?
Precision Biologics is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Is Precision Biologics a funded company?
Precision Biologics is a funded company, having raised a total of $14.58M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3.29M, raised on May 21, 2013.
How many employees does Precision Biologics have?
As of Dec 31, 2022, the latest employee count at Precision Biologics is 4.
What does Precision Biologics do?
Precision Biologics is engaged in the development of innovative therapeutic and diagnostic products for cancer patients. The company operates in the biotechnology sector, specializing in cancer therapeutics. Its solutions include patient tumor-derived anticancer vaccines, targeted monoclonal antibodies, and antibody-drug conjugates like PB-223 ADC. These products are designed to address unmet needs in cancer treatment by targeting tumors without harming healthy cells. Research and development efforts are supported by a unique discovery platform and breakthroughs in biotechnology.
Who are the top competitors of Precision Biologics?
Precision Biologics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Precision Biologics offer?
Precision Biologics offers Anticancer Vaccines, Monoclonal Antibodies, and Antibody-Drug Conjugate PB-223 ADC.
How many acquisitions has Precision Biologics made?
Precision Biologics has made 1 acquisition, including Neogenix Oncology.
Who are Precision Biologics's investors?
Precision Biologics has 1 investor. Key investors include NantWorks.